Gruber James R.
SEC CIK 1923165 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | CFO | 213.4K | — | $673.7K | 3 | 2025-08-19 | 2026-01-14 |
Most active insiders at ETON, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | — | $9.91M |
| 2 | Opaleye Management Inc. | 10% | — | $6.89M |
| 3 | MAIER PAUL V | Dir | — | $5.91M |
| 4 | Krempa David | Chief Business Off | — | $4.86M |
| 5 | Adams Jennifer McKie | Dir | — | $1.62M |
| 6 | Erdogan-Trinkaus Ipek | Chief Commercial Off | — | — |
| 7 | Gruber James R. | CFO | — | — |
| 8 | RIEDEL NORBERT G | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-14 | 2026-01-14 | ETON | Eton Pharmaceuticals, Inc. | Gruber James R. | CFO | F - Tax | $15.47 | -2,293 | 213.4K | -1% | -$35.5K |
| D | 2025-12-12 | 2025-12-12 | ETON | Eton Pharmaceuticals, Inc. | Gruber James R. | CFO | F - Tax | $16.99 | -4,542 | 215.7K | -2% | -$77.2K |
| M | 2025-08-20 | 2025-08-19+ | ETON | Eton Pharmaceuticals, Inc. | Gruber James R. | CFO | S - Sale | $16.15 | -41.7K | 205.3K | -17% | -$673.7K |
Purchase Sale Sale after option exercise All abbreviations